Product logins

Find logins to all Clarivate products below.


The US ENT device market was severely impacted by the COVID-19 pandemic in 2020, but has already shown significant recovery in 2021 and 2022. Growth over the forecast period will be driven mainly by rising myringotomy tube sales as well as RF and powered instruments, whereas growing clinical evidence will boost adoption of drug-eluting sinus stents. The hand instruments sector will be the slowest growing segment due to the mature nature of the market and lack of innovation.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for ENT devices in the US from 2019 through 2031.

Related Medtech Insights Reports

Report
Spinal Implants | Market Insights | US | 2023
Following the impact of the COVID-19 pandemic, the US spinal implant market will continue to be characterized by strong pressure on device prices. This trend will be mitigated to some extent by…
Report
Interventional Cardiology Devices | Market Insights | US | 2023
The global COVID-19 pandemic has had a negative impact on the IC device market to some extent. The US IC device market is mature and facing intense pricing pressure on established products,…
Report
Peripheral Vascular Devices | Market Insights | Europe | 2023
The COVID-19 pandemic had a negative impact on the European PV device market in 2020, and to some extent in 2021 and 2022. Following the impact of the pandemic, increasing physician awareness…
Report
Trauma Devices | Market Insights | US | 2023
Given the urgent nature of the procedures within the trauma device market, the impact of the COVID-19 pandemic was less severe and the recovery was relatively fast for the US trauma device…
Report
Dialysis Access Treatment Devices | Market Insights | Europe | 2023
The COVID-19 pandemic had a negative impact on the European dialysis access treatment device market in 2020, and to some extent in 2021. Once the market stabilizes, the European dialysis access…